Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2025
    • ACR Convergence 2025
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023

Latest Articles

  • You have access
    Should potassium-competitive acid blockers replace proton pump inhibitors as first-line therapy for patients with severe (Los Angeles grade C or D) esophagitis?
    Sandra Elmasry, MD, Allon Kahn, MD, Lisa Marks, MLS, AHIP and Neera Agrwal, MD, PhD
    Cleveland Clinic Journal of Medicine February 2026, 93 (2) 84-87; DOI: https://doi.org/10.3949/ccjm.93a.25044

    Potassium-competitive acid blockers are reserved for patients who cannot tolerate proton pump inhibitors or who do not respond to them.

  • You have access
    A new direction in pain management?
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine February 2026, 93 (2) 67-68; DOI: https://doi.org/10.3949/ccjm.93b.02026

    It would be nice to have a treatment option for pain that is less limited by side effects, cognitive dysfunction, addiction potential, and red tape.

  • You have access
    Suzetrigine: A novel nonopioid systemic analgesic
    Anthony E. Divito, MD, Matthew Sharobeem, DO, Gausan R. Bajracharya, MD and Basem B. Abdelmalak, MD
    Cleveland Clinic Journal of Medicine February 2026, 93 (2) 94-98; DOI: https://doi.org/10.3949/ccjm.93a.25087

    The systemic sodium channel blocker suzetrigine may serve as another option for multimodal postoperative analgesia regimens and for managing acute nonsurgical pain.

  • You have access
    Teprotumumab for thyroid eye disease: A reality check
    Julian Perry, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 702-703; DOI: https://doi.org/10.3949/ccjm.92a.25066

    Initial enthusiasm for teprotumumab as therapy for thyroid eye disease has been tempered by longitudinal data suggesting that it often does not alter the natural disease course.

  • You have access
    Thyroid eye disease: What’s the latest?
    CME article
    Ashley B. Vincent, DO, Alexander R. Engelmann, MD, Catherine J. Hwang, MD and Christian Nasr, MD
    Cleveland Clinic Journal of Medicine November 2025, 92 (11) 693-701; DOI: https://doi.org/10.3949/ccjm.92a.25043

    A better understanding of the pathophysiology of this autoimmune disorder has led to innovative insights into its treatment, but long-term management remains a challenge.

  • You have access
    Optimizing hypertension treatment: Evidence-based approaches and new drugs
    CME article
    Astefanos Al-Dalakta, MD, Ahmad Ghanem, MD, Chadi Tabaja, MD, Issam Motairek, MD, Abdel Hadi El Hajjar, MD and Luke J. Laffin, MD
    Cleveland Clinic Journal of Medicine September 2025, 92 (9) 555-564; DOI: https://doi.org/10.3949/ccjm.92a.24119

    The authors discuss current evidence-based approaches to managing hypertension and optimizing blood pressure control through a series of cases representing common clinical scenarios.

  • You have access
    Benzodiazepines: Caught between patient needs and guidelines
    Jasleen Kaur, MD, Vania Modesto-Lowe, MD, MPH and Margaret M. Chaplin, MD
    Cleveland Clinic Journal of Medicine September 2025, 92 (9) 531-535; DOI: https://doi.org/10.3949/ccjm.92a.25019

    Negative sentiment about benzodiazepines has intensified in recent years, and there is increasing emphasis on deprescribing even for people who have had no ill effects from them.

  • You have access
    Flexibility is warranted in applying prescribing guidelines
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine September 2025, 92 (9) 520-521; DOI: https://doi.org/10.3949/ccjm.92b.09025

    Discontinuation of benzodiazepines in chronic users may be associated with a small increase in mortality and a higher risk of adverse events, especially in the short term after cessation.

  • You have access
    An overview of over-the-counter contraceptives: Spotlight on daily oral norgestrel
    Rujuta Takalkar, BS, Andrea Lorenzo, MD, MS and Suneela Vegunta, MD, NCMP
    Cleveland Clinic Journal of Medicine September 2025, 92 (9) 572-576; DOI: https://doi.org/10.3949/ccjm.92a.24108

    Oral norgestrel, the first daily oral contraceptive pill available over the counter in the United States, is a safe, effective addition to existing over-the-counter contraceptive options.

  • You have access
    In Reply: Insomnia in older adults
    Margaret M. Chaplain, MD, Roberto León-Barriera, MD and Vania Modesto-Lowe, MD, MPH
    Cleveland Clinic Journal of Medicine March 2025, 92 (3) 144; DOI: https://doi.org/10.3949/ccjm.92c.03005

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 30

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2026 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire